Please assess the completion status of the following clinical trial:

Trial Title: Phase 1B Study of KSP/QRH Dimer for Detection of Neoplasia in the Esophagus

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Has known or suspected Barrett's esophagus~* Scheduled for a clinically-indicated, upper endoscopy~* Subject is medically cleared for the procedure (e.g. washout for anticoagulants, co-morbidities)~* Age 18 to 100 years~* Willing and able to sign informed consent~Exclusion Criteria:~* Subjects with known allergy or negative reaction to the near infrared fluorophore IRDye800CW, or derivatives~* Subjects on active chemotherapy or radiation treatment~* Pregnant or trying to conceive

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- Esophagus sprayed with KSP/QRH dimer (Type: EXPERIMENTAL): Area of interest in subject's esophagus sprayed with KSP/QRH dimer and imaged with the SFE probe

Based on this trial design, predict the completion outcome and termination type (if applicable).